New glucose monitor aims for better accuracy and safety in diabetes care

NCT ID NCT07518004

Recruiting now Disease control Sponsor: Senseonics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new continuous glucose monitoring system called ROME GS in 60 adults with type 1 or type 2 diabetes. The goal is to see if it measures blood sugar accurately and is safe to use. Participants will wear the sensor and have their glucose levels checked against a standard lab test.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Continuous glucose monitoring system (device)
What this could lead to: If successful, this could lead to a more accurate and safer continuous glucose monitor for people with diabetes, helping them better manage their blood sugar levels.
What could go wrong: This is an early-stage study with only 60 participants, so results may not apply to everyone. The device may not be more accurate or safer than existing monitors, and there are risks like infection or discomfort from sensor insertion.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 1 diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES DIABETES MELLETUS, TYPE 1 DIABETES MELLITUS TYPE 2

Contacts and locations

Locations

Flourish Research - Diablo Clinical Research
NOT_YET_RECRUITING

Walnut Creek, California, 94598, United States
Flourish Research - San Antonio
RECRUITING

San Antonio, Texas, 78229, United States
Headlands Research - AMCR Institute
RECRUITING

Escondido, California, 92025, United States
Rainier Clinical Research Center
RECRUITING

Renton, Washington, 98057, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.